Evidence map›Paper›PMID 42171752›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Deleterious in vitro effects of ammonia and accumulated urea cycle amino acids on leukocyte DNA: assessment of the antioxidant effects of N-acetylcysteine and L-carnitine.

Franciele Fátima Lopes, Jéssica Lamberty Faverzani, Bianca Gomes Dos Reis, Ana Kalise Böttcher, Luisa Maria Bosquetti Tedesco, Stefani Altenhofen, Laura Smolski Dos Santos, Gênifer Erminda Schreiner, Vanusa Manfredini, Moacir Wajner and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Franciele Fátima LopesPrograma de Pós-Graduação Em Ciências Farmacêuticas, Universidade Federal Do Rio Grande Do Sul, Porto Alegre, Brazil. franciele.f.lopes@gmail.com.
Jéssica Lamberty FaverzaniServiço de Genética Médica, Hospital de Clínicas de Porto Alegre, R. Ramiro Barcelos, Porto Alegre, RS, CEP, 2350, Brazil.
Bianca Gomes Dos ReisServiço de Genética Médica, Hospital de Clínicas de Porto Alegre, R. Ramiro Barcelos, Porto Alegre, RS, CEP, 2350, Brazil.
Ana Kalise BöttcherServiço de Genética Médica, Hospital de Clínicas de Porto Alegre, R. Ramiro Barcelos, Porto Alegre, RS, CEP, 2350, Brazil.
Luisa Maria Bosquetti TedescoServiço de Genética Médica, Hospital de Clínicas de Porto Alegre, R. Ramiro Barcelos, Porto Alegre, RS, CEP, 2350, Brazil.
Stefani AltenhofenServiço de Genética Médica, Hospital de Clínicas de Porto Alegre, R. Ramiro Barcelos, Porto Alegre, RS, CEP, 2350, Brazil.
Laura Smolski Dos SantosUniversidade Federal Do Pampa (UNIPAMPA), Campus Uruguaiana, Uruguaiana, Brazil.
Gênifer Erminda SchreinerUniversidade Federal Do Pampa (UNIPAMPA), Campus Uruguaiana, Uruguaiana, Brazil.
Vanusa ManfrediniUniversidade Federal Do Pampa (UNIPAMPA), Campus Uruguaiana, Uruguaiana, Brazil.
Moacir WajnerServiço de Genética Médica, Hospital de Clínicas de Porto Alegre, R. Ramiro Barcelos, Porto Alegre, RS, CEP, 2350, Brazil.
Carmen Regla VargasPrograma de Pós-Graduação Em Ciências Farmacêuticas, Universidade Federal Do Rio Grande Do Sul, Porto Alegre, Brazil. crvargas@hcpa.edu.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The urea cycle is essential for ammonia detoxification. Deficiencies in this pathway cause urea cycle disorders (UCDs), characterized by hyperammonemia and severe systemic and neurological manifestations. While ammonia toxicity is well established, the contribution of urea cycle altered amino acids that accumulate in specific UCDs to cellular stress and DNA damage-associated responses remains poorly understood. This study investigated the DNA damage effects of ornithine (1 mM), homocitrulline (0.5 mM), citrulline (1 mM), and arginine (1 mM), alone and combined with ammonia (1 mM), in human peripheral leukocytes, as well as the protective effects of N-acetylcysteine (1 mM) and L-carnitine (60 µM). DNA damage was evaluated using the comet assay and statistically analyzed. All treatments induced significant DNA damage compared with controls. When tested individually at pathophysiologically relevant concentrations, urea cycle-related metabolites produced measurable increases in DNA damage, with citrulline and arginine inducing damage comparable to ammonia. Homocitrulline also caused DNA damage, to a lesser extent, while ornithine induced the lowest levels among isolated treatments. Combined exposure to ammonia and amino acids markedly increased DNA damage levels compared with isolated conditions, emphasizing the impact of metabolic imbalance in UCDs. The highest DNA damage indices were observed with ornithine and homocitrulline in the presence of ammonia, indicating potential synergistic interactions. L-carnitine significantly reduced DNA damage in all experimental conditions. N-acetylcysteine also reduced DNA damage effects in most combinations, except for ornithine with ammonia. Overall, these findings demonstrate that both isolated and combined UCD-related metabolites are associated with increased DNA damage under hyperammonemic conditions and support antioxidant strategies as potential complementary approaches to mitigate genomic stress in UCDs.

Indexed as

AcetylcysteineAmino AcidsAmmoniaAntioxidantsCarnitineDNA DamageLeukocytesUreaArginineCitrullineComet AssayHumansOrnithineAcetylcysteineAmino AcidsAmmoniaAntioxidantsArginineCarnitineCitrullinehomocitrullineOrnithineUreaAmino acid metabolismAntioxidant therapyComet assayDNA damageHyperammonemiaUrea cycle disorders

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.